Lysine supplement benefit, does it prevent herpes?
October 2 2016 by
Ray Sahelian, M.D.
L Lysine is an amino acid that contains two amino groups, neither of which can undergo direct transamination. L Lysine is degraded by a complex pathway in which saccharopine, alpha ketoadipate, and crotonyl CoA are intermediates. Ultimately lysine generates acetyl CoA for the production of energy.
Availability
You can find l lysine capsules and powder as supplements.
Life Extension, L-Lysine, 620 mg, 100 Veggie Caps
purchase L-Lysine supplement, Source Naturals
L-Lysine is an essential free-form
amino acid which acts as a precursor for
other amino acids, including L-carnitine (needed for fat metabolism). It
is crucial for the formation of collagen, a major part of the body's connective
tissues. It also contributes to energy production when converted to acetyl
coenzyme A, one of the principal fuels for the Krebs cycle.
Supplement Facts:
L-Lysine (HCI) - 1,000 mg
Suggested Use: One lysine tablet daily, or as recommended by your health care
professional.
Purchase Lysine supplement
Lysine and herpes simplex
At this point, it appears that some studies show lysine to be helpful in herpes treatment or prevention, but several more studies are needed to confirm or refute these findings before we can make any firm recommendations for the use of lysine in herpes treatment. My overall impression thus far is that if lysine does help a herpes infection or if lysine prevents a herpes infection, its effects are most likely mild. Although the role of lysine in herpes has been studied off an on for quite a number of years, no firm conclusions can yet be made. I have listed some of the L lysine and herpes studies at the bottom of the page. The ideal dosage of lysine for herpes prevention is not known at this time and the long term side effects of lysine, if any, are also not known. Thus far no significant l lysine side effects have been reported in the medical literature.
Schizophrenia
J Psychiatr Res. 2014. L-lysine as an adjunct to risperidone in patients with
chronic schizophrenia: a double-blind, placebo-controlled, randomized trial.
Increasing evidence suggest that the nitric oxide signaling system of the brain
may contribute to the pathophysiology of schizophrenia, making this system a
target for development of novel therapeutics. The objective of this study was to
investigate the efficacy and safety of L-lysine as an adjunctive to risperidone
in the treatment of patients with chronic schizophrenia during an 8-week trial.
Seventy-two chronic schizophrenia inpatients with a Positive and Negative
Syndrome Scale (PANSS) total score of ≥ 60 participated in a randomized,
double-blind, placebo-controlled trial in the active phase of their disease and
underwent 8 weeks of treatment with either L-lysine (6 g/day) or placebo as an
adjunctive to risperidone. Patients were evaluated using PANSS and its subscales
at baseline and weeks 2, 4, 6 and 8. The primary outcome measure was to evaluate
the efficacy of L-lysine in improving schizophrenia symptoms. Repeated measures
analysis demonstrated significant effect for time × treatment interaction on the
PANSS total, negative and general psychopathology subscale scores but not the
PANSS positive subscale scores. The frequency of adverse events (AEs) did not
differ significantly between the two treatment groups and no serious AE was
observed. The present study demonstrated that l-lysine can be a tolerable and
efficacious adjunctive therapy for improving negative and general
psychopathology symptoms in chronic schizophrenia. However, the safety and
efficacy of higher doses of l-lysine and longer treatment periods still remain
unknown.
Carnitine and L Lysine
Carnitine is
synthesized primarily in the liver and kidneys from lysine and
methionine.
Carnitine covers an important role in lipid metabolism, acting as an
obligatory cofactor for beta-oxidation of fatty acids by facilitating the
transport of long-chain fatty acids across the mitochondrial membrane as
acylcarnitine esters. Furthermore, since carnitine
behaves as a shuttle
for acetyl groups from inside to outside the mitochondrial membrane, it
covers also a key role in glucose metabolism and assists in fuel-sensing.
A reduction of the fatty acid transport inside the mitochondria results in
the cytosolic accumulation of triglycerides, which is implicated in the
pathogenesis of insulin resistance.
Clin Ther. 2012. Effect of lysine, vitamin B(6), and carnitine supplementation on the lipid profile of male patients with hypertriglyceridemia: a 12-week, open-label, randomized, placebo-controlled trial.H Fat metabolism is known to be altered in hypertriglyceridemia. Fat oxidation requires carnitine, which can be obtained either from the diet (animal or dairy products) or through synthesis in the body using both lysine and vitamin B(6). The goal of this study was to investigate the effect of lysine, vitamin B(6), and carnitine supplementation on both glycemia and the lipid profiles, specifically triglyceride (TG) levels, in men with hypertriglyceridemia. This 12-week, randomized, placebo-controlled clinical trial was conducted at a Lebanese medical center. A total of 85 hypertriglyceridemic (TG> 150 mg/dL) male patients were randomized to 1 of 5 groups and given supplements of lysine (1 g/d), vitamin B(6) (50 mg/d), lysine (1 g/d) + vitamin B6 50 mg/d, carnitine 1 g/d, or placebo for 12 weeks. The lipid profile (TG, total cholesterol, LDL-C, and HDL-C) and fasting plasma glucose levels were assessed at baseline and at 6 and 12 weeks. Adults (∼50 years) Lebanese males from a low socioeconomic status in Beirut were given the appropriate supplements. Vitamin B(6) supplementation was associated with a significant reduction in total cholesterol and HDL-C of ∼10%. In addition, plasma TG was reduced by 36.6 mg/dL at 6 weeks, whereas levels in the placebo group increased by 18 mg/dL; this difference failed to reach statistical significance. No major changes in the lipid profile were observed in the lysine and carnitine groups or when lysine was added to vitamin B(6). Vitamin B(6) supplementation in these male patients with hypertriglyceridemia reduced plasma total cholesterol and HDL-C concentrations.
L Lysine
Research
Safety and effectiveness of an L-lysine, zinc, and herbal-based
product on the treatment of facial and circumoral Herpes.
Alternative Med Rev. 2005. Singh BB, Udani J, Vinjamury SP,
Der-Martirosian C, Gandhi S. Professor of Research and Senior Scientist, Southern California University
of Health Sciences. Correspondence address: SCU Research Division,
Whittier, California
L-lysine, an essential amino acid, inhibits normal replication of
Herpes simplex virus (HSV), shortening the normal course and duration of
the disease. This study was conducted to determine the effectiveness of a
combination of L-lysine with botanicals and other nutrients in relieving
the symptoms of facial and circumoral herpes. This small pilot
study was conducted using an outcome (open-label) model. Thirty male and
female participants (15 in each group) meeting the inclusion/exclusion
criteria were admitted to the study. The 10 outcome measures used to
monitor the sores were tingling, itching, burning, tenderness, prickling,
soreness, bump/swelling, small blister(s), oozing blisters, and
crusting, as well as before-and-after photographs of the lesion, and a
daily diary. At the end of treatment the ointment produced full
resolution in 40 percent of the participants by the third day and in 87
percent by the end of the sixth day. A cold sore episode may last up to 21
days without treatment. Overall data indicated significant
improvement in participants by the sixth day of treatment for all but two
participants. There were no adverse effects reported during this study.
Thirteen-week oral toxicity study of L-lysine hydrochloride in rats.
Int J Toxicology. 2004.
L-Lysine hydrochloride is an essential amino acid in humans and
animals, and it is used in animal feeds, in prevention of herpes simplex
recurrence, and cereal fortification in some developing countries. This
study evaluated toxicological and behavioral effects of Lys during a
dosing study with male and female Sprague-Dawley rats. The amino acid was
incorporated into a standard diet at doses equal to 1.25%, 2.5%, and 5.0%
(w/w). A control group of rats received a standard diet. All diets were
administered ad libitum for 13 consecutive weeks. To examine stability of
any potential effects, the administration period was followed by a 5-week
recovery period, during which only the standard diet was provided to all
animals. In male and female rats in each concentration group,
treatment-related changes were not observed in the clinical signs, body
weights, diet consumption, water intake, ophthalmology, gross pathology,
organ weights, or histology. A Lys-related drop in serum concentration and
an increase in urine excretion of chlorides was a compensatory reaction to
the ingested hydrochloride. No functional, biochemical, or histological
changes in renal function were found. The no-observed-adverse-effect level
(NOAEL) for Lys was estimated at 5% for both genders.
Success
of L-lysine therapy in frequently recurrent herpes simplex infection.
Treatment and prophylaxis.
Dermatologica. 1987.
Griffith RS, Walsh DE, Myrmel KH.
Department of Medicine, Indiana University School of Medicine,
Indianapolis.
A double-blind, placebo-controlled, multicenter trial of oral L-lysine
monohydrochloride for the prevention and treatment of recurrent herpes
simplex (HSV) infection was conducted. The treatment group was given
L-Lysine monohydrochloride tablets (1,000 mg L-lysine per dose) 3 times a
day for 6 months. A total of 27 (6 male and 21 female) subjects on
L-lysine and 25 (6 male and 19 female) subjects on placebo completed the
trial. The L-lysine treatment group had an average of 2.4 less HSV infections, symptoms were significantly (p less than 0.05)
diminished in severity and healing time was significantly reduced (p less
than 0.05). L-Lysine appears to be an effective agent for reduction of
occurrence, severity and healing time for recurrent HSV infection.
Lysine as
a prophylactic agent in the treatment of recurrent herpes simplex labialis.
Oral Surg Oral Med Oral Pathol. 1984.
This study
examined the efficacy of long-term prophylactic lysine supplementation.
Twenty-six volunteers with a history of frequently recurring herpetic
lesions completed a 12-month double-blind crossovers study. The
experimental group received daily oral supplements of 1,000 mg 1-lysine.
Serum samples were analyzed at scheduled intervals. In most instances,
members of the lysine group reported significantly fewer lesions than the
control group. Similarly, those who were taken off lysine supplementation
generally showed a significant increase in lesion frequency. Quantitative
hematologic measurements revealed the most clinically useful relationship.
Data from this sample population indicated that when a person's serum
lysine concentration exceeded 165 nmol/ml there was a corresponding
significant decrease in recurrence rate. Conversely, the frequency rate
increased significantly as concentration levels fell below 165 nmol/ml.
These results suggest that prophylactic lysine may be useful in managing
selected cases of recurrent herpes simplex labialis if serum lysine levels
can be maintained at adequate concentrations.
Questions
Q. i wonder if you have any thoughts on this problem my daughter
suffers from a recurring herpetic problem which in the past has responded
well to lysine. however as the mother of a 23 month old baby boy who
is still breastfeeding only at night - is it still the case that lysine
should be avoided.
A. We have not seen much research regarding the use of
lysine during breastfeeding. It would appear to be safe, but we can't be
for sure.
Q. Can lysine be taken the same day as
dmae bitartrate,
tongkat ali,
choline bitartrate,
or saw palmetto?
A. I don't see why not.
Q. I have
recurrent cold sore problem and want to use l lysine to prevent it. How
effective is lysine for cold sore problem?
A. Some of the research regarding the amino acid l
lysine and cold sore infection appears to be promising, but a few more
longer term trials would give us a clearer idea.
Q. I read
on a website that food high in lysine such as yogurt or cheese can help
with cold sores. Is that true?
A. I have seen such claims regarding foods high in
lysine and low in arginine as being beneficial for cold sore prevention,
but have not seen such research. At this time I am skeptical of this
approach. I think it is not worthwhile to change the type of food you eat
just for the sake of potential herpes prevention. It may be too much
effort for little or no benefit. It would be much easier to give a l
lysine supplement a trial for a few months to see if it helps with herpes
recurrence prevention. Just monitor your herpes outbreaks and document
them to see if the l lysine capsule made a difference.
Q. Is
there a benefit to L Lysine supplement use besides potential herpes
prevention?
A. I don't know any other reason to take it
besides for herpes.
Q. I am
prone to cold sores and take 1,000mg of lysine a day. Can I also take
arginine (a lower dose than lysine at 500mg) for its effects as well
without
increasing the possibility of an outbreak? Is that even enough arginine
via supplementation?
A. We don't know what affect the arginine combined with lysine will
have, if any.
Q. I have found Lysine useful for keeping herpes suppressed and have been taking 1,000 - 1,500 mg a day for some years. I tried the Source Naturals Lysine. Although the 1,000mg dose is convenient, I find the capsules not only very large, but they have sharp edges and a relatively course surface - all of which make for difficult or even slightly dangerous-feeling swallowing. So, I have to look for another source of Lysine.
Any
information on taking L-lysine 2-4 hours after a person takes the arginine
to reduce the likelyhood of herpes outbreak?
I have not seen any studies on the role of lysine supplements
taken before arginine in terms of herpes outbreak.
In one of your
articles you indicated that you did not know of other uses for l-lysine other
than herpes. Well three time Nobel prize winner Dr Linus Pauling proved in his
laboratory that high doses of L-lysine and vitamin C cleaned the plack out of
your arteries and if you add Proline the effect is done quicker. Go to the
Vitamin C foundation on the net they have the data. I have been taking their
supplement for over a year and it lowered my blood pressure in addition. thought
you should know. My cat had a candida infection in his eye, 500mg of l-lysine
each day cured it in one week.
I have not seen any long term formal studies in humans
regarding the claims you mention. Was the candida in the eye of the cat proven
by testing? Many infections clear up on their own. I appreciate anecdotal
information but prefer that they be replicated by others or in a formal
investigation.
I would like to
take L Arginine to enhance the production of Nitric Oxide, but the last time I
took it, I came down with Herpes. I understand that 5gs of L Arginine or more
sometimes activates the Herpes Zoster virus. I also understand that taking L
Lysine helps neutralize that affect. I took the 5 g for several weeks and then
had Herpes along the back and ribs for the first time.My question is, if I take
5 g of L Arginine and 5 g of L Lysine together, will the L Arginine still
enhance Nitric Oxide and would the L Lysine prevent the Herpes Zoster virus from
utilizing the L Arginine for reproduction? I have Googled these questions and
can't seem to get a specific answer. I'm sure many people have wondered this
besides me, since it seems that most of my friends are familiar with the
relationships of these two amino acids and Herpes.
We have not seen any studies that address this quesiton.